Medical Cannabis for Treating Pain Related to Fibromyalgia
Phase 4
Completed
- Conditions
- Fibromyalgia
- Interventions
- Drug: Bedrocan®-type cannabis (22% THC, <1% CBD)
- First Posted Date
- 2023-07-11
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Universita degli Studi della Basilicata
- Target Recruit Count
- 30
- Registration Number
- NCT05939466
- Locations
- 🇮🇹
Pain Therapy Unit, San Carlo Hospital, Potenza, Italy
© Copyright 2025. All Rights Reserved by MedPath